Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hercz

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Dialysis|February 24, 2001
Regulation of bone remodeling: impact of novel therapiesG Hercz
The American Journal of the Medical Sciences|June 18, 1999
Relative hypoparathyroidism and adynamic bone diseaseI Mucsi, G Hercz
Current Opinion in Nephrology and Hypertension|July 1, 1997
Adynamic bone disease: pathogenesis, diagnosis and clinical relevanceI Mucsi, G Hercz
Kidney International|July 14, 2006
Reversal of adynamic bone disease by lowering of dialysate calciumA Haris, D J Sherrard, G Hercz
Biological Trace Element Research|January 1, 1994
Hair trace elements in kidney dialysis patients by INAAR E Jervis, B T Kua, G Hercz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
The aplastic form of renal osteodystrophyD J Sherrard, G Hercz, Y Pei, et al.
The Journal of Rheumatology|March 1, 1990
Osteonecrosis in patients receiving dialysis: report of two cases and review of the literatureP Langevitz, D Buskila, J Stewart, et al.
Bone|January 31, 2004
Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophyA H M Ng, G Hercz, R Kandel, et al.
Kidney International|May 9, 1998
Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysisI Mucsi, G Hercz, R Uldall, et al.
Kidney International|December 1, 1986
Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamineG Hercz, I B Salusky, K C Norris, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Dialysis|February 24, 2001
Regulation of bone remodeling: impact of novel therapiesG Hercz
The American Journal of the Medical Sciences|June 18, 1999
Relative hypoparathyroidism and adynamic bone diseaseI Mucsi, G Hercz
Current Opinion in Nephrology and Hypertension|July 1, 1997
Adynamic bone disease: pathogenesis, diagnosis and clinical relevanceI Mucsi, G Hercz
Kidney International|July 14, 2006
Reversal of adynamic bone disease by lowering of dialysate calciumA Haris, D J Sherrard, G Hercz
Biological Trace Element Research|January 1, 1994
Hair trace elements in kidney dialysis patients by INAAR E Jervis, B T Kua, G Hercz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
The aplastic form of renal osteodystrophyD J Sherrard, G Hercz, Y Pei, et al.
The Journal of Rheumatology|March 1, 1990
Osteonecrosis in patients receiving dialysis: report of two cases and review of the literatureP Langevitz, D Buskila, J Stewart, et al.
Bone|January 31, 2004
Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophyA H M Ng, G Hercz, R Kandel, et al.
Kidney International|May 9, 1998
Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysisI Mucsi, G Hercz, R Uldall, et al.
Kidney International|December 1, 1986
Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamineG Hercz, I B Salusky, K C Norris, et al.
Pageof 3